Figure 1:
Fluorescence intensities (tumor – contralateral side) over the observation period of 48 h, including two injection points at times 0 and 24 h: (A) BT-474 and (B) MD-MBA-361.
Fluorescence intensities (tumor – contralateral side) over the observation period of 48 h, including two injection points at times 0 and 24 h: (A) BT-474 and (B) MD-MBA-361.